Elevance Health Reports Third Quarter 2022 Results, Raises Full Year Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Elevance (ELV) PT Raised to $571 at Jefferies
October 20, 2022 8:48 AM EDTJefferies analyst David Windley raised the price target on Elevance (NYSE: ELV) to $571.00 (from $569.00) while maintaining a Buy rating.
The analyst commented, "LV's membership growth continues to be impressive, having eclipsed UNH in total members in the last 12 months. Government growth plus solid... More
Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue
October 19, 2022 6:03 AM EDTElevance Health Inc. (NYSE: ELV) reported Q3 EPS of $7.53, $0.37 better than the analyst estimate of $7.16. Revenue for the quarter came in at $39.6 billion versus the consensus estimate of $39.26 billion.
GUIDANCE:
Elevance Health Inc. sees FY2022 EPS of $28.95.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
... More